Sinco Pharmaceuticals Holdings Limited

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Rok finansowy 2013 2013 2014 2014 2015 2015 2016 2016 2017 2017 2018 2018 2019 2019 2020 2020 2021 2021 2022 2022 2023 2023 2024 2024
Kwartał Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4
Data 2013-06-30 2014-01-31 2014-06-30 2014-12-31 2015-06-30 2015-12-31 2016-06-30 2016-12-31 2017-06-30 2017-12-31 2018-06-30 2018-12-31 2019-06-30 2019-12-31 2020-06-30 2020-12-31 2021-06-30 2021-12-31 2022-06-30 2022-12-31 2023-06-30 2023-12-31 2024-06-30 2024-12-31
Przychód (mln) 295 238 415 535 609 487 569 290 414 392 574 379 535 641 636 1,413 847 1,177 1,130 1,142 1,090 1,450 1,527 1,294
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 106.4% 105.2% 37.3% -45.91% -31.92% -19.50% 0.8% 30.9% 29.2% 63.4% 10.9% 272.9% 58.2% 83.6% 77.6% -19.24% 28.7% 23.2% 35.1% 13.4%
Marża brutto 9.7% 13.7% 15.1% 12.5% 13.6% 14.3% 14.6% 7.4% 6.3% 10.8% 19.1% -1.71% 17.0% 20.1% 17.1% 11.7% 18.6% 17.6% 17.0% 10.0% 14.0% 11.8% 11.3% 9.8%
Koszty i Wydatki (mln) 270 211 365 486 547 456 525 301 444 528 605 586 504 610 605 1,303 744 1,093 1,042 1,118 1,044 1,393 1,469 1,271
EBIT (mln) 27 22 53 52 66 40 46 -15 -14 -71 -37 -180 19 39 29 115 106 87 81 20 56 60 58 24
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 149.9% 78.6% -13.51% -128.85% -121.26% -277.47% -180.69% 1089.3% 236.9% 154.9% 178.2% 163.8% 446.9% 123.6% 179.9% -82.35% -46.75% -30.72% -28.45% 16.5%
EBIT (%) 9.2% 9.4% 12.8% 9.8% 10.9% 8.2% 8.0% -5.23% -3.41% -18.03% -6.44% -47.50% 3.6% 6.1% 4.5% 8.1% 12.5% 7.4% 7.2% 1.8% 5.2% 4.2% 3.8% 1.8%
Przychody fiansowe (mln) 1 0 3 2 4 3 4 3 7 24 20 14 10 10 1 4 12 8 9 2 4 0 0 0
Koszty finansowe (mln) -2 2 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Amortyzacja (mln) 1 0 1 1 5 5 5 5 8 8 5 5 5 5 5 4 2 3 3 4 5 6 7 11
EBITDA (mln) 27 23 54 54 71 45 51 -10 -7 -63 -32 -175 24 43 34 118 108 90 84 25 61 66 79 54
EBITDA(%) 9.4% 9.6% 12.9% 10.0% 11.7% 9.2% 9.0% -3.37% -1.59% -16.06% -5.52% -46.15% 4.5% 6.8% 5.3% 8.4% 12.8% 7.6% 7.5% 2.2% 5.6% 4.6% 5.1% 4.2%
NOPLAT (mln) 27 23 47 47 58 29 40 -15 -36 -159 -51 -221 22 21 30 106 92 76 79 21 43 57 68 31
Podatek (mln) 5 3 7 6 9 8 10 3 4 5 3 11 7 13 2 20 16 16 17 13 23 34 44 13
Zysk Netto (mln) 17 20 34 35 49 21 31 -12 -32 -154 -49 -232 15 8 32 86 75 60 62 8 20 23 24 18
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 195.0% 4.4% -9.16% -133.25% -164.72% -838.11% -256.90% 1882.7% 148.2% 105.4% 166.6% 137.0% 395.0% 616.6% 90.8% -91.20% -73.97% -61.95% -61.45% 141.1%
Zysk netto (%) 6.9% 8.4% 8.2% 6.6% 8.0% 4.3% 5.5% -4.04% -7.61% -39.35% -8.49% -61.17% 2.8% 1.3% 5.1% 6.1% 8.9% 5.1% 5.5% 0.7% 1.8% 1.6% 1.6% 1.4%
EPS 0.0137 0.0167 0.0285 0.0293 0.0406 0.0174 0.0213 -0.0072 -0.02 -0.0956 -0.029 -0.14 0.009 0.0049 0.0192 0.0506 0.0445 0.0336 0.0305 0.0035 0.0096 0.0112 0.0117 0.0089
EPS (rozwodnione) 0.0137 0.0167 0.0285 0.0293 0.0406 0.0174 0.0213 -0.0072 -0.0195 -0.0956 -0.0289 -0.14 0.009 0.0049 0.0192 0.0506 0.0445 0.0335 0.0305 0.0037 0.0096 0.0112 0.0117 0.0083
Ilośc akcji (mln) 1,200 1,200 1,200 1,200 1,200 1,200 1,456 1,616 1,576 1,615 1,681 1,692 1,692 1,692 1,692 1,692 1,692 1,782 2,032 2,145 2,031 2,035 2,033 2,201
Ważona ilośc akcji (mln) 1,200 1,200 1,200 1,200 1,200 1,200 1,455 1,616 1,615 1,615 1,685 1,692 1,692 1,692 1,692 1,692 1,692 1,783 2,032 2,032 2,031 2,035 2,033 2,033
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY